Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The APOBEC3C crystal structure and the interface for HIV-1 Vif binding.
Kitamura S, Ode H, Nakashima M, Imahashi M, Naganawa Y, Kurosawa T, Yokomaku Y, Yamane T, Watanabe N, Suzuki A, Sugiura W, Iwatani Y. Kitamura S, et al. Among authors: yokomaku y. Nat Struct Mol Biol. 2012 Oct;19(10):1005-10. doi: 10.1038/nsmb.2378. Epub 2012 Sep 23. Nat Struct Mol Biol. 2012. PMID: 23001005
Interference between D30N and L90M in selection and development of protease inhibitor-resistant human immunodeficiency virus type 1.
Sugiura W, Matsuda Z, Yokomaku Y, Hertogs K, Larder B, Oishi T, Okano A, Shiino T, Tatsumi M, Matsuda M, Abumi H, Takata N, Shirahata S, Yamada K, Yoshikura H, Nagai Y. Sugiura W, et al. Among authors: yokomaku y. Antimicrob Agents Chemother. 2002 Mar;46(3):708-15. doi: 10.1128/AAC.46.3.708-715.2002. Antimicrob Agents Chemother. 2002. PMID: 11850252 Free PMC article.
Use of new T-cell-based cell lines expressing two luciferase reporters for accurately evaluating susceptibility to anti-human immunodeficiency virus type 1 drugs.
Chiba-Mizutani T, Miura H, Matsuda M, Matsuda Z, Yokomaku Y, Miyauchi K, Nishizawa M, Yamamoto N, Sugiura W. Chiba-Mizutani T, et al. Among authors: yokomaku y. J Clin Microbiol. 2007 Feb;45(2):477-87. doi: 10.1128/JCM.01708-06. Epub 2006 Dec 20. J Clin Microbiol. 2007. PMID: 17182760 Free PMC article.
HIV-2 CRF01_AB: first circulating recombinant form of HIV-2.
Ibe S, Yokomaku Y, Shiino T, Tanaka R, Hattori J, Fujisaki S, Iwatani Y, Mamiya N, Utsumi M, Kato S, Hamaguchi M, Sugiura W. Ibe S, et al. Among authors: yokomaku y. J Acquir Immune Defic Syndr. 2010 Jul;54(3):241-7. doi: 10.1097/QAI.0b013e3181dc98c1. J Acquir Immune Defic Syndr. 2010. PMID: 20502347
High performance liquid chromatography using UV detection for the simultaneous quantification of the new non-nucleoside reverse transcriptase inhibitor etravirine (TMC-125), and 4 protease inhibitors in human plasma.
Hirano A, Takahashi M, Kinoshita E, Shibata M, Nomura T, Yokomaku Y, Hamaguchi M, Sugiura W. Hirano A, et al. Among authors: yokomaku y. Biol Pharm Bull. 2010;33(8):1426-9. doi: 10.1248/bpb.33.1426. Biol Pharm Bull. 2010. PMID: 20686242 Free article.
Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in Japan.
Hattori J, Shiino T, Gatanaga H, Yoshida S, Watanabe D, Minami R, Sadamasu K, Kondo M, Mori H, Ueda M, Tateyama M, Ueda A, Kato S, Ito T, Oie M, Takata N, Hayashida T, Nagashima M, Matsuda M, Ibe S, Ota Y, Sasaki S, Ishigatsubo Y, Tanabe Y, Koga I, Kojima Y, Yamamoto M, Fujita J, Yokomaku Y, Koike T, Shirasaka T, Oka S, Sugiura W. Hattori J, et al. Among authors: yokomaku y. Antiviral Res. 2010 Oct;88(1):72-9. doi: 10.1016/j.antiviral.2010.07.008. Epub 2010 Aug 6. Antiviral Res. 2010. PMID: 20692295
82 results